• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1994年默克弗罗斯特奖。非甾体抗炎药(NSAID)引起胃肠道损伤的机制——开发胃肠道安全性高的NSAIDs的潜力。

The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.

作者信息

Wallace J L

机构信息

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, AB, Canada.

出版信息

Can J Physiol Pharmacol. 1994 Dec;72(12):1493-8. doi: 10.1139/y94-215.

DOI:10.1139/y94-215
PMID:7736340
Abstract

Nonsteroidal anti-inflammatory drugs are widely used for the treatment of osteoarthritis and rheumatoid arthritis, but their ability to cause gastrointestinal bleeding is a significant limitation to this use. A better understanding of the pathogenesis of gastric and intestinal injury induced by these agents will permit the rational design of anti-inflammatory drugs that spare the gastrointestinal tract. In this review, the mechanisms through which nonsteroidal anti-inflammatory drugs are believed to cause gastrointestinal ulceration are reviewed. Several strategies that are being employed to develop gastrointestinal-sparing drugs are outlined.

摘要

非甾体抗炎药被广泛用于治疗骨关节炎和类风湿性关节炎,但其导致胃肠道出血的能力严重限制了其在这方面的应用。更好地了解这些药物引起胃肠道损伤的发病机制,将有助于合理设计出能避免胃肠道损伤的抗炎药物。在这篇综述中,我们将回顾非甾体抗炎药被认为导致胃肠道溃疡的机制。同时概述目前正在采用的几种开发保护胃肠道药物的策略。

相似文献

1
The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.1994年默克弗罗斯特奖。非甾体抗炎药(NSAID)引起胃肠道损伤的机制——开发胃肠道安全性高的NSAIDs的潜力。
Can J Physiol Pharmacol. 1994 Dec;72(12):1493-8. doi: 10.1139/y94-215.
2
Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem.非甾体抗炎药引起的胃肠道毒性:对一个老问题的新见解。
J Gastroenterol. 1997 Feb;32(1):127-33. doi: 10.1007/BF01213310.
3
Use of NSAIDs. An assault on the upper gastrointestinal tract.非甾体抗炎药的使用。对上消化道的一种侵害。
Postgrad Med. 1994 Nov 1;96(6):63-8.
4
Considerations for nonsteroidal anti-inflammatory drug therapy: safety.非甾体抗炎药治疗的考量因素:安全性
Scand J Rheumatol Suppl. 1996;105:13-24; discussion 25-7. doi: 10.3109/03009749609097232.
5
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].[非甾体抗炎药所致胃肠道溃疡及其并发症的防治建议]
Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021.
6
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.非甾体抗炎药与胃肠道
Gastroenterologist. 1994 Sep;2(3):207-23.
7
NSAID gastroenteropathy: past, present and future.非甾体抗炎药胃肠病:过去、现在与未来
Can J Gastroenterol. 1996 Nov-Dec;10(7):451-9. doi: 10.1155/1996/850710.
8
Non-steroidal anti-inflammatory drugs: how do they damage the gut?非甾体抗炎药:它们如何损害肠道?
Br J Rheumatol. 1994 Jul;33(7):605-12. doi: 10.1093/rheumatology/33.7.605.
9
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: novel gastrointestinal-sparing drugs.释放一氧化氮的非甾体抗炎药:新型胃肠道保护药物。
Mini Rev Med Chem. 2001 May;1(1):57-70. doi: 10.2174/1389557013407160.
10
The epidemiology of nonsteroidal anti-inflammatory drugs.非甾体抗炎药的流行病学
Can J Gastroenterol. 1999 Mar;13(2):119-22. doi: 10.1155/1999/361651.

引用本文的文献

1
Tissue damage and oxidant/antioxidant balance.组织损伤与氧化/抗氧化平衡。
Eurasian J Med. 2013 Feb;45(1):47-9. doi: 10.5152/eajm.2013.08.
2
Synthesis, characterization and pharmacological evaluation of 1-(2-chloro-6-fluorophenyl)-5-methylindolin-2-one: a new anti-inflammatory compound with reduced gastric ulceration properties.1-(2-氯-6-氟苯基)-5-甲基吲哚啉-2-酮的合成、表征及药理学评价:一种新型具有降低胃溃疡特性的抗炎化合物。
Molecules. 2010 Nov 8;15(11):8039-47. doi: 10.3390/molecules15118039.
3
Synthesis, ex vivo and in vitro hydrolysis study of an indoline derivative designed as an anti-inflammatory with reduced gastric ulceration properties.
一种设计用于抗炎且具有减轻胃溃疡特性的吲哚啉衍生物的合成、体外和体内水解研究。
Molecules. 2009 Aug 26;14(9):3187-97. doi: 10.3390/molecules14093187.
4
Lipopolysaccharide from Escherichia coli prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence.大肠杆菌脂多糖可预防大鼠吲哚美辛诱导的胃损伤:非蛋白巯基和白细胞黏附的作用。
Inflamm Res. 2009 Oct;58(10):717-23. doi: 10.1007/s00011-009-0040-8. Epub 2009 Apr 29.
5
Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety.阿西美辛对白细胞黏附信号通路缺乏影响可能解释了其胃肠道安全性。
Br J Pharmacol. 2008 Nov;155(6):857-64. doi: 10.1038/bjp.2008.316. Epub 2008 Aug 11.
6
Ex vivo effects of lysine clonixinate on cyclooxygenases in rat lung and stomach preparations.赖氨酸氯尼辛对大鼠肺和胃组织中环氧化酶的离体作用。
Inflammopharmacology. 1999;7(4):401-11. doi: 10.1007/s10787-999-0033-9.
7
Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism.阿司匹林诱导人胃黏膜细胞死亡:支持凋亡机制的证据
Dig Dis Sci. 2004 Sep;49(9):1518-25. doi: 10.1023/b:ddas.0000042258.41480.30.
8
Nitric oxide-releasing NSAIDs: a review of their current status.释放一氧化氮的非甾体抗炎药:现状综述
Drug Saf. 2001;24(11):801-11. doi: 10.2165/00002018-200124110-00002.
9
Apoptosis of rat gastric mucosa and of primary cultures of gastric epithelial cells by indomethacin: role of inducible nitric oxide synthase and interleukin-8.吲哚美辛诱导大鼠胃黏膜及胃上皮细胞原代培养物凋亡:诱导型一氧化氮合酶和白细胞介素-8的作用
Int J Exp Pathol. 2001 Aug;82(4):221-9. doi: 10.1111/j.1365-2613.2001.iep0082-0221-x.
10
Rheumatology: 7. Basics of therapy.风湿病学:7. 治疗基础。
CMAJ. 2000 Aug 22;163(4):417-23.